|
|
||||||||

,

*
Department of Neuroimmunology, Max-Planck Institute for Neurobiology, Martinsried, Germany;
Department of Neuroimmunology, Brain Research Institute University of Vienna, Vienna, Austria;
Department of Neurology, University of Graz, Graz, Austria; and
§
Department of Animal and Avian Sciences, University of Maryland, College Park, MD 20742
Experimental autoimmune encephalomyelitis (EAE) induced by sensitization with myelin oligodendrocyte glycoprotein (MOG) is a T cell-dependent autoimmune disease that reproduces the inflammatory demyelinating pathology of multiple sclerosis. We report that an encephalitogenic T cell response to MOG can be either induced or alternatively suppressed as a consequence of immunological cross-reactivity, or "molecular mimicry" with the extracellular IgV-like domain of the milk protein butyrophilin (BTN). In the Dark Agouti rat, active immunization with native BTN triggers an inflammatory response in the CNS characterized by the formation of scattered meningeal and perivascular infiltrates of T cells and macrophages. We demonstrate that this pathology is mediated by a MHC class II-restricted T cell response that cross-reacts with the MOG peptide sequence 7687, IGEGKVALRIQN (identities underlined). Conversely, molecular mimicry with BTN can be exploited to suppress disease activity in MOG-induced EAE. We demonstrate that not only is EAE mediated by the adoptive transfer of MOG7490 T cell lines markedly ameliorated by i.v. treatment with the homologous BTN peptide, BTN7490, but that this protective effect is also seen in actively induced disease following transmucosal (intranasal) administration of the peptide. These results identify a mechanism by which the consumption of milk products may modulate the pathogenic autoimmune response to MOG.
This article has been cited by other articles:
![]() |
E. K. Mathey, T. Derfuss, M. K. Storch, K. R. Williams, K. Hales, D. R. Woolley, A. Al-Hayani, S. N. Davies, M. N. Rasband, T. Olsson, et al. Neurofascin as a novel target for autoantibody-mediated axonal injury J. Exp. Med., October 1, 2007; 204(10): 2363 - 2372. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Otaegui, S. Mostafavi, C. C. A. Bernard, A. L. de Munain, P. Mousavi, J. R. Oksenberg, and S. E. Baranzini Increased Transcriptional Activity of Milk-Related Genes following the Active Phase of Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis J. Immunol., September 15, 2007; 179(6): 4074 - 4082. [Abstract] [Full Text] [PDF] |
||||
![]() |
R P Lisak, J A Benjamins, B Bealmear, B Yao, S Land, L Nedelkoska, and D Skundric Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for immune-related molecules by central nervous system mixed glial cell cultures Multiple Sclerosis, April 1, 2006; 12(2): 149 - 168. [Abstract] [PDF] |
||||
![]() |
K. L. Reichelt and O. Skjeldal IgA antibodies in Rett syndrome. Autism, March 1, 2006; 10(2): 189 - 197. [Abstract] [PDF] |
||||
![]() |
I. Tsunoda, J. E. Libbey, L.-Q. Kuang, E. J. Terry, and R. S. Fujinami Massive Apoptosis in Lymphoid Organs in Animal Models for Primary and Secondary Progressive Multiple Sclerosis Am. J. Pathol., December 1, 2005; 167(6): 1631 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Spitsberg Invited Review: Bovine Milk Fat Globule Membrane as a Potential Nutraceutical J Dairy Sci, July 1, 2005; 88(7): 2289 - 2294. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bischof, A. Bins, M. Durr, Y. Zevering, A. Melms, and A. M. Kruisbeek A Structurally Available Encephalitogenic Epitope of Myelin Oligodendrocyte Glycoprotein Specifically Induces a Diversified Pathogenic Autoimmune Response J. Immunol., July 1, 2004; 173(1): 600 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mana, M. Goodyear, C. Bernard, R. Tomioka, M. Freire-Garabal, and D. Linares Tolerance induction by molecular mimicry: prevention and suppression of experimental autoimmune encephalomyelitis with the milk protein butyrophilin Int. Immunol., March 1, 2004; 16(3): 489 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kawakami, S. Lassmann, Z. Li, F. Odoardi, T. Ritter, T. Ziemssen, W. E.F. Klinkert, J. W. Ellwart, M. Bradl, K. Krivacic, et al. The Activation Status of Neuroantigen-specific T Cells in the Target Organ Determines the Clinical Outcome of Autoimmune Encephalomyelitis J. Exp. Med., January 20, 2004; 199(2): 185 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Guggenmos, A. S. Schubart, S. Ogg, M. Andersson, T. Olsson, I. H. Mather, and C. Linington Antibody Cross-Reactivity between Myelin Oligodendrocyte Glycoprotein and the Milk Protein Butyrophilin in Multiple Sclerosis J. Immunol., January 1, 2004; 172(1): 661 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Breithaupt, A. Schubart, H. Zander, A. Skerra, R. Huber, C. Linington, and U. Jacob Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein PNAS, August 5, 2003; 100(16): 9446 - 9451. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bourquin, A. Schubart, S. Tobollik, I. Mather, S. Ogg, R. Liblau, and C. Linington Selective Unresponsiveness to Conformational B Cell Epitopes of the Myelin Oligodendrocyte Glycoprotein in H-2b Mice J. Immunol., July 1, 2003; 171(1): 455 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Weissert, J. Kuhle, K. L. de Graaf, W. Wienhold, M. M. Herrmann, C. Muller, T. G. Forsthuber, K.-H. Wiesmuller, and A. Melms High Immunogenicity of Intracellular Myelin Oligodendrocyte Glycoprotein Epitopes J. Immunol., July 1, 2002; 169(1): 548 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Winer, I. Astsaturov, R. K. Cheung, K. Schrade, L. Gunaratnam, D. D. Wood, M. A. Moscarello, P. O'Connor, C. McKerlie, D. J. Becker, et al. T Cells of Multiple Sclerosis Patients Target a Common Environmental Peptide that Causes Encephalitis in Mice J. Immunol., April 1, 2001; 166(7): 4751 - 4756. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |